Activation of voltage-gated KCNQ/Kv7 channels by anticonvulsant retigabine attenuates mechanical allodynia of inflammatory temporomandibular joint in rats

W Xu, Y Wu, Y Bi, L Tan, Y Gan, KW Wang - Molecular Pain, 2010 - journals.sagepub.com
Background: Temporomandibular disorders (TMDs) are characterized by persistent orofacial
pain and have diverse etiologic factors that are not well understood. It is thought that central …

Temporomandibular joint inflammation decreases the voltage-gated K+ channel subtype 1.4-immunoreactivity of trigeminal ganglion neurons in rats

M Takeda, T Tanimoto, M Nasu, S Matsumoto - European journal of pain, 2008 - Elsevier
Voltage-gated K+ (Kv) channels are one of the important physiological regulators of the
membrane potentials in excitable cells, including sensory ganglion neurons. The aim of the …

Suppression of KCNQ/M potassium channel in dorsal root ganglia neurons contributes to the development of osteoarthritic pain

F Zhang, Y Liu, D Zhang, X Fan, D Shao, H Li - Pharmacology, 2019 - karger.com
Osteoarthritic pain has a strong impact on patients' quality of life. Understanding the
pathogenic mechanisms underlying osteoarthritic pain will likely lead to the development of …

Activation of peripheral KCNQ channels attenuates inflammatory pain

H Hayashi, M Iwata, N Tsuchimori… - Molecular …, 2014 - journals.sagepub.com
Background: Refractory chronic pain dramatically reduces the quality of life of patients.
Existing drugs cannot fully achieve effective chronic pain control because of their lower …

Orofacial neuropathic pain induced by oxaliplatin: downregulation of KCNQ2 channels in V2 trigeminal ganglion neurons and treatment by the KCNQ2 channel …

J Ling, F Erol, V Viatchenko-Karpinski… - Molecular …, 2017 - journals.sagepub.com
Neuropathic pain induced by chemotherapy drugs such as oxaliplatin is a dose-limiting side
effect in cancer treatment. The mechanisms underlying chemotherapy-induced neuropathic …

Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model

Q Zheng, D Fang, M Liu, J Cai, Y Wan, JS Han… - PAIN®, 2013 - Elsevier
Bone cancer pain has a strong impact on the quality of life of patients, but is difficult to treat.
Better understanding of the pathogenic mechanisms underlying bone cancer pain will likely …

Potassium channels as a potential therapeutic target for trigeminal neuropathic and inflammatory pain

M Takeda, Y Tsuboi, J Kitagawa… - Molecular …, 2011 - journals.sagepub.com
Previous studies in several different trigeminal nerve injury/inflammation models indicated
that the hyperexcitability of primary afferent neurons contributes to the pain pathway …

Activation of neuronal voltage-gated potassium Kv7/KCNQ/M-current by a novel channel opener SCR2682 for alleviation of chronic pain

J Wang, Y Liu, F Hu, J Yang, X Guo, X Hou, C Ju… - … of Pharmacology and …, 2021 - ASPET
Treatment of chronic pain remains an unmet medical need. The neuronal voltage-gated
potassium Kv7/KCNQ/M channel has been implicated as a therapeutic target for chronic …

[HTML][HTML] CENTRAL ROLE OF PROTEIN KINASE A IN PROMOTING TRIGEMINAL NOCICEPTION IN AN IN VIVO MODEL OF TEMPOROMANDIBULAR JOINT …

LK Koop, JL Hawkins, LE Cornelison… - … of oral & facial pain and …, 2017 - ncbi.nlm.nih.gov
Aims To investigate cellular changes in the spinal trigeminal nucleus (STN) and trigeminal
ganglion associated with trigeminal nociception mediated by inflammation in the …

KCNQ2/3/5 channels in dorsal root ganglion neurons can be therapeutic targets of neuropathic pain in diabetic rats

T Yu, L Li, H Liu, H Li, Z Liu, Z Li - Molecular Pain, 2018 - journals.sagepub.com
Background Diabetic neuropathic pain is poorly controlled by analgesics, and the precise
molecular mechanisms underlying hyperalgesia remain unclear. The KCNQ2/3/5 channels …